By Marc Zimmer New London: During her chemistry Nobel Prize lecture in 2018, Frances Arnold said, “Today we can for all practical purposes read, write and edit any sequence of DNA, but we cannot compose it.” That isn’t true anymore. Since then, science and technology have progressed so much that artificial intelligence has learned to … Read more
Bengaluru: Unlearn.AI, which has built a machine learning platform that creates “digital twin” profiles of patients in clinical trials, has raised $15 million to expand partnerships and accelerate regulatory approval, the company told Reuters on Tuesday. The investment from Radical Ventures and Wittington Ventures valued the startup at $265 million, the company said. Mira Murati, … Read more
The vaccine’s maker says it is effective in preventing infection and transmission of the disease. Source link
Many parents have been pushing for an expansion of shots to toddlers and preschoolers, especially as the omicron wave sent record numbers of youngsters to the hospital. Pfizer on Wednesday asked the US to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to … Read more
By Rajiv Mathur India possesses some of the best assets in healthcare – highly qualified doctors and scientists; a world-class infrastructure of private hospitals; a huge population base to not only conduct robust clinical trials but also provide requisite manpower to the healthcare industry. In recent times, the young population of India has also demonstrated … Read more
CoviTechTM vaccine may have the potential to address the burning issue of mutations, especially the ‘Variants of Concern’ (VOC) which has been hammering countries through subsequent waves of infection. TechInvention Lifecare Pvt. Ltd., a Biotech start-up company based out of Mumbai, India has revealed positive outcomes of its recombinant subunit SARS-CoV-2 vaccine (CoviTechTM) in a … Read more
NEW DELHI: A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country’s immunisation campaign, cyber intelligence firm Cyfirma told Reuters. Rivals China and India have both sold or gifted Covid-19 shots to many countries. India produces more than … Read more
By Cristin Flanagan Biotech mania has overtaken internet chat rooms, pushing aside recent retail trading stars GameStop Corp. and Express Inc. Cassava Sciences Inc. nabbed the top spot as best microcap stock performer this year with an almost 680% rally. The small drug developer now has a market value of nearly $2 billion after briefly … Read more
It aims to inoculate some 300m people this year in one of the world’s largest vaccination campaigns. Source link
Bharat Biotech has been granted permission to start the Phase III trials of Covaxin – India’s indigenous Covid-19 vaccine candidate. [REPRESENTATIVE IMAGE] File photo of Covaxin (Picture Courtesy: Twitter @airnewsalerts) The Drug Controller General of India (DGCI) on Thursday allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate … Read more